Daisuke Sueta

4.4k citations
201 papers · 3.5k · 1 hit paper · h-index 30

Impact in

    • Blood Pressure and Hypertension Studies
    • Heart Failure Treatment and Management
    • Cardiovascular Health and Disease Prevention
    • Renin-Angiotensin System Studies
    • Venous Thromboembolism Diagnosis and Management

Papers in

    • Heart Failure Treatment and Management 14
    • Antiplatelet Therapy and Cardiovascular Diseases 13
    • Blood Pressure and Hypertension Studies 13
    • Chemotherapy-induced cardiotoxicity and mitigation 12
    • Atrial Fibrillation Management and Outcomes 11
    • Venous Thromboembolism Diagnosis and Management 37

Daisuke Sueta

189 papers receiving 3.4k citations

Daisuke Sueta's Hit Papers

Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice 2014 · 362 citations
3620+4+8Years since publication100200300

Peers

Daisuke Sueta
Comparison fields: 5 of 107
  • Cardiology and Cardiovascular Medicine 1.5k
  • Internal Medicine 182
  • Neurology 216
  • Endocrinology, Diabetes and Metabolism 367
  • Nephrology 125
Replace Hiroaki Kawano with:
Hiroaki Kawano Japan
Masaharu Akao Japan
Mišo Šabović Slovenia
Minako Yamaoka‐Tojo Japan
Masashi Akaike Japan
Naoyuki Hasebe Japan
Toshio Nishikimi Japan
Speranza Rubattu Italy
Toshiaki Ebina Japan
Massimo Puato Italy
Daisuke Sueta relative to Hiroaki Kawano Japan Hiroaki Kawano's profile →
Citations per field
00.5×2×4×5.2×
Hiroaki Kawano · 1×
Citations per year

Countries citing papers authored by Daisuke Sueta

Since Specialization
Citations

This map shows the geographic impact of Daisuke Sueta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daisuke Sueta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daisuke Sueta more than expected).

Fields of papers citing papers by Daisuke Sueta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daisuke Sueta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daisuke Sueta. The network helps show where Daisuke Sueta may publish in the future.

Co-authors

The 25 scholars most cited alongside Daisuke Sueta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daisuke Sueta Line = papers co-authored together Daisuke Sueta links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 201 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice
Hit paper breakdown →
2014362
2 2017219
3 2011129
4 201192
5 201381
6 201777
7 201968
8 201567
9 201664
10 201664
11 201758
12 201754
13 201451
14 201350
15 201649
16 201848
17 201347
18 202047
19 201446
20 201342

About Daisuke Sueta

Daisuke Sueta is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine, Surgery, Endocrinology, Diabetes and Metabolism and Neurology, having authored 201 papers that have together received 3.5k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (37 papers), Coronary Interventions and Diagnostics (19 papers), Heart Failure Treatment and Management (14 papers), Antiplatelet Therapy and Cardiovascular Diseases (13 papers), Blood Pressure and Hypertension Studies (13 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (13 papers), Chemotherapy-induced cardiotoxicity and mitigation (12 papers) and Atrial Fibrillation Management and Outcomes (11 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.5k citations), Internal Medicine (182 citations), Neurology (216 citations), Endocrinology, Diabetes and Metabolism (367 citations) and Nephrology (125 citations). Daisuke Sueta has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Shokei Kim‐Mitsuyama, Nobutaka Koibuchi, Eiichiro Yamamoto, Kensuke Toyama, Hisao Ogawa, Koichi Kaikita, Seiji Hokimoto, Yu Hasegawa, Ken Uekawa and Mingjie Ma. Their work appears in journals such as International Journal of Cardiology, Journal of the American Heart Association, Circulation Journal, ESC Heart Failure and American Journal of Hypertension.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact